Data / Drug companies / Miers Laboratories
Miers Laboratories: 10 products in the FDA NDC directory, labeler code 59672
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Miers Laboratories (labeler code 59672) lists 10 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 5 over the counter drugs, 5 drugs for further processing. Its main marketing category is unapproved homeopathic products. The newest product started marketing on August 5, 2023.
The request: Watch Miers Laboratories (FDA labeler code 59672): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 59672
- Products in commercial distribution
- 10
- Packages
- 10
- Finished drugs by generic name
- 1
- Prescription products
- 0
- Over the counter products
- 5
- Flagged as original packager
- 5 of 5 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 15, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Unapproved homeopathic products | 5 | 50% |
| Drugs for further processing | 5 | 50% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 5 | 50% |
| Drugs for further processing | 5 | 50% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Graphite, thuja occidentalis leafy twig, and silicon dioxide | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 10 | 100% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Trip ease | 59672-1716 | Tablet | Unapproved homeopathic products | August 5, 2023 |
| Activated charcoal, sodium phosphate, dibasic, heptahydrate, and strychnos nux-vomica seed | 59672-2516 | Tablet | Drugs for further processing | December 2, 2022 |
| Arnica montana whole, rhododendron tomentosum leafy twig, toxicodendron pubescens leaf, and ruta graveolens flowering top | 59672-0016 | Tablet | Drugs for further processing | December 2, 2022 |
| Drink Ease | 59672-1516 | Tablet | Unapproved homeopathic products | January 28, 2022 |
| Arabica coffee bean, passiflora incarnata flowering top, and valerian | 59672-1316 | Tablet | Drugs for further processing | May 1, 2021 |
| Sodium borate, anamirta cocculus seed, gelsemium sempervirens root, wood creosote, toxicodendron pubescens leaf, and tobacco leaf | 59672-1716 | Tablet | Drugs for further processing | December 6, 2019 |
| Arnica montana, bellis perennis, matricaria chamomilla, ipecac, and lycopdoium clavatum spore | 59672-1116 | Tablet | Drugs for further processing | March 4, 2019 |
| No-jet-lag | 59672-0117 | Tablet | Unapproved homeopathic products | December 3, 2018 |
| No-Shift-Lag | 59672-0230 | Tablet | Unapproved homeopathic products | January 20, 2016 |
| No-weak-nails | 59672-0916 | Tablet | Unapproved homeopathic products | September 15, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.